Breaking News

Gene Therapy Co. Selects ValGenesis’ SaaS Platform

VLMS to digitize Its global validation programs.

By: Contract Pharma

Contract Pharma Staff

ValGenesis, Inc., a provider of in Enterprise Validation Lifecycle Management Systems (VLMS), was selected by a gene therapy company to digitize its corporate validation process. The company discovers and develops gene therapies that are helping patients overcome limitations in genetic disease.   ValGenesis VLMS offers remote validation capability and is designed to enable efficient change and risk management to help achieve better control over these processes. ValGenesis VLMS expedites protoc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters